Experimental type 1 diabetes drug protects pancreatic cells from immune system attack
Scientists at the Johns Hopkins School of Medicine say an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice…